XML 16 R54.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations Company recognized loss on exit (Details) (USD $)
Jun. 30, 2012
Jun. 30, 2011
Mar. 31, 2012
Regenerative Medicine - China segment [Member]
Dec. 31, 2011
Regenerative Medicine - China segment [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Cash $ 16,149,188 $ 2,875,232 $ 195,100 $ 103,300
Prepaid expenses and other current assets     14,900 284,400
Property, plant and equipment, net     1,023,700 1,256,800
Other Assets     330,500 149,000
Accounts payable     (177,100) 177,800
Accrued liabilities     (79,200) 31,000
Accumulated comprehensive income     (169,900)  
Loss on exit of segment     1,138,000 1,793,500
Liabilities of Disposal Group, Including Discontinued Operation       $ 208,800